These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
7651 related items for PubMed ID: 2438872
21. Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues. Morishima T, Tatsumi F, Fukada E, Watanabe M, Nagashima N, Hanawa S. Arch Dermatol Res; 1983; 275(5):329-33. PubMed ID: 6419680 [Abstract] [Full Text] [Related]
22. Some indolic compounds as markers of the melanocyte activity. Hansson C. Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811 [Abstract] [Full Text] [Related]
23. Melanin-related biochemistry of IGR 1 human melanoma cells. Karg E, Odh G, Rosengren E, Wittbjer A, Rorsman H. Melanoma Res; 1991; 1(1):5-13. PubMed ID: 1822769 [Abstract] [Full Text] [Related]
25. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype]. Nozawa S, Ohta H, Tsukazaki K, Udagawa Y, Kurihara S, Kano S. Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036 [Abstract] [Full Text] [Related]
26. Oxidation of dopa in the skin of black and albino mice. Carstam R, Hansson C, Rorsman H, Rosengren E. Acta Derm Venereol; 1986 Jun; 66(5):369-74. PubMed ID: 2431571 [Abstract] [Full Text] [Related]
27. Tyrosinase activity in the medium of human melanoma cell cultures. Jergil B, Lindbladh C, Rorsman H, Rosengren E. Acta Derm Venereol; 1983 Jun; 63(3):205-8. PubMed ID: 6192632 [Abstract] [Full Text] [Related]
28. Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid. Hansson C, Rorsman H, Rosengren E. Acta Derm Venereol; 1981 Jun; 61(2):147-8. PubMed ID: 6165191 [Abstract] [Full Text] [Related]
29. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione. Benathan M, Virador V, Furumura M, Kobayashi N, Panizzon RG, Hearing VJ. Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002 [Abstract] [Full Text] [Related]
33. Differentiation of melanocytes in cultures of primary malignant melanoma indicated by 5-S-cysteinyldopa formation. Aubert C, Rosengren E, Rorsman H, Rougé F. J Natl Cancer Inst; 1975 Dec; 55(6):1327-8. PubMed ID: 1206755 [Abstract] [Full Text] [Related]
34. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography. Hansson C, Edholm LE, Agrup G, Rorsman H, Rosengren AM, Rosengren E. Clin Chim Acta; 1978 Sep 15; 88(3):419-27. PubMed ID: 699334 [Abstract] [Full Text] [Related]
35. A new amino acid, 3-(2,5-SS-dicysteinyl-3,4-dihydroxyphenyl)alanine, from the tapetum lucidum of the gar (Lepisosteidae) and its enzymic synthesis. Ito S, Nicol JA. Biochem J; 1977 Mar 01; 161(3):499-507. PubMed ID: 403909 [Abstract] [Full Text] [Related]
36. Evidence for covalent lipoyl adduction with dopaquinone following tyrosinase-catalyzed oxidation. Tsuji-Naito K, Hatani T, Okada T, Tehara T. Biochem Biophys Res Commun; 2006 Apr 28; 343(1):15-20. PubMed ID: 16527255 [Abstract] [Full Text] [Related]
38. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma. Graef V, Paul E. Br J Dermatol; 1982 Jan 28; 106(1):53-7. PubMed ID: 6800394 [Abstract] [Full Text] [Related]
39. Tyrosinase and gamma-glutamyl transpeptidase in 5-s-cysteinyldopa genesis within melanotic and amelanotic melanomas. Mojamdar M, Ichihashi M, Mishima Y. J Dermatol; 1982 Feb 28; 9(1):73-7. PubMed ID: 6124565 [No Abstract] [Full Text] [Related]